Abstract
Surfactant replacement therapy in surfactant deficiency has been shown to be an effective method to improve lung function. The immediate beneficial effects of surfactant therapy, however, are often followed by a relapse within several hours after treatment. In premature newborn infants factors responsible for the relapse include patency of the ductus arteriosus and inhibition of surfactant activity by proteins leaking into the alveolar space. Other factors which are possibly of significant importance are the initial distribution of the administered surfactant throughout and its further distribution in time. So far little is known about the distribution of instilled natural surfactant in surfactant deficiency.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Noack G, Berggren P, Curstedt T, Grossmann G, Herin P, Mortensson W, Nilson R, Robertson B (1987) Severe neonatal respiratory distress syndrome treated with the isolated fraction of natural surfactant. Acta Paediatr Scand 76: 697–705
Köler G, Milstein C (1975) Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256: 495–497
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Oetomo, S.B., de Ley, L., Schoots, C., Lachmann, B., Okken, A. (1988). Immunohistochemical Study of the Distribution of Exogenous Surfactant in the Lungs of Surfactant-Deficient Rabbits Using a Monoclonal Antibody. In: Lachmann, B. (eds) Surfactant Replacement Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73305-5_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-73305-5_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73307-9
Online ISBN: 978-3-642-73305-5
eBook Packages: Springer Book Archive